Used as an intermediate in the synthesis of biologically active compounds, particularly in pharmaceutical research targeting central nervous system disorders. Its structure supports the development of novel neuroactive agents due to the presence of a bromophenyl group and a constrained pyrrolidine-pyran ring system, which can enhance binding selectivity. Commonly employed in medicinal chemistry for constructing complex heterocyclic frameworks in drug discovery programs.